news
Sanofi Pasteur’s Dengvaxia approved in the Philippines
Dengvaxia is the first vaccine licensed for the prevention of dengue in the world...
List view / Grid view
Vaccines
article
Excipient selection in biologics and vaccines formulation development
19 February 2014 | By M. Babu Medi and Ramesh Chintala, Vaccine Drug Product Development, Merck & Co, Inc and Akhilesh Bhambhani, Novel Adjuvants, Formulation and Delivery Technologies, Merck & Co, Inc.
Excipients are an integral part of pharmaceutical products and play an important role in the formulation development of both small and large molecule pharmaceuticals. The type and extent of excipient use depends on several factors, including the type of active ingredient, route of administration, dosage form, target population and indication…
news
Lonza announces successful completion of new GMP suite for growing viral vaccine and gene therapy business
Lonza, a global leader in the field of biologics manufacturing, today announced the successful completion of its new GMP clean room within its Houston, Texas operations. The clean room supports multiple types of viral vector and viral vaccine projects, with working volumes up to 2,000 liters.
